Otolaryngology‐Head and Neck Surgery
Eli O. Meltzer(University of California, San Diego), Daniel L. Hamilos(Massachusetts General Hospital), James A. Hadley(University of Rochester), Donald C. Lanza, Bradley F. Marple(The University of Texas Southwestern Medical Center), Richard A. Nicklas(George Washington University), Claus Bachert(Universitair Ziekenhuis Brussel), James N. Baraniuk(George Washington University), Fuad M. Baroody, Michael S. Benninger, Itzhak Brook(Georgetown University), Badrul A. Chowdhury, Howard M. Druce(Rutgers New Jersey Medical School), Stephen R. Durham(Imperial College London), Berrylin J. Ferguson(University of Pittsburgh), Jack M. Gwaltney(University of Virginia), Michael Kaliner(George Washington University), David W. Kennedy(University of Pennsylvania), Valerie J. Lund(University College London), Robert M. Naclerio, Ruby Pawankar(Nippon Medical School Hospital), Jay F. Piccirillo(Washington University in St. Louis), Patricia Rohane, Ronald A. Simon(Scripps Clinic), Raymond G. Slavin(Saint Louis University), Alkis Togias(Johns Hopkins University), Ellen R. Wald, S. James Zinreich(Johns Hopkins University)
Cited by 559Open Access
Abstract
ogy (ACAAI); and the American Rhinologic Society (ARS), convened a group of 30 physicians from a wide range of disciplines: allergy-immunology, otolaryngology, infectious disease, and radiology. Over 2 days, this panel worked together to develop definitions of rhinosinusitis for clinical research and to suggest clinical trial designs for studies that would allow for more appropriate use of pharmacologic, immunologic, and surgical interventions. Using an anonymous electronic audience response system, the committee was able to Institutes of Health; and is employed by Georgetown University. F. M. Baroodyis on the Speaker's Bureaufor Merck& Co, Inc, and GlaxoSmith-Kline.
Related Papers
No related papers found
Powered by citation graph analysis